J Valencak

Summary

Affiliation: University of Vienna
Country: Austria

Publications

  1. ncbi Positron emission tomography with [18F] 2-fluoro-D-2- deoxyglucose in primary cutaneous T-cell lymphomas
    Julia Valencak
    Haematologica 89:115-6. 2004
  2. ncbi Carbamazepine-induced DRESS syndrome with recurrent fever and exanthema
    Julia Valencak
    Department of Dermatology, Division of General Dermatology, University of Vienna, Vienna, Austria
    Int J Dermatol 43:51-4. 2004
  3. ncbi Selective immunohistochemical staining shows significant prognostic influence of lymphatic and blood vessels in patients with malignant melanoma
    J Valencak
    Department of Dermatology, University of Vienna, Wahringer Gurtel 18 20, A 1090 Wien, Austria
    Eur J Cancer 40:358-64. 2004
  4. doi Dermal infiltrates of cutaneous T-cell lymphomas with epidermotropism but not other cutaneous lymphomas are abundant with langerin⁺ dendritic cells
    M Der-Petrossian
    Department of Dermatology, Division of General Dermatology, Medical University of Vienna, Vienna, Austria
    J Eur Acad Dermatol Venereol 25:922-7. 2011
  5. doi Prognostic relevance of hypoxia inducible factor-1alpha expression in patients with melanoma
    J Valencak
    Department of Dermatology, Medical University of Vienna, Vienna, Austria
    Clin Exp Dermatol 34:e962-4. 2009
  6. doi Somatostatin receptor scintigraphy in primary cutaneous T- and B-cell lymphomas
    J Valencak
    Department of Dermatology, Medical University of Vienna, Vienna, Austria
    J Eur Acad Dermatol Venereol 24:13-7. 2010
  7. doi Rituximab monotherapy for primary cutaneous B-cell lymphoma: response and follow-up in 16 patients
    J Valencak
    Department of Dermatology, Medical University of Vienna, Austria
    Ann Oncol 20:326-30. 2009
  8. pmc Treatment of advanced pancreatic cancer with the long-acting somatostatin analogue lanreotide: in vitro and in vivo results
    M Raderer
    Department of Internal Medicine I, University of Vienna, Austria
    Br J Cancer 79:535-7. 1999
  9. pmc Importance of extensive staging in patients with mucosa-associated lymphoid tissue (MALT)-type lymphoma
    M Raderer
    Department of Internal Medicine I, University of Vienna, Austria
    Br J Cancer 83:454-7. 2000
  10. ncbi Molecular cytogenetic evidence of t(14;18)(IGH;BCL2) in a substantial proportion of primary cutaneous follicle center lymphomas
    Berthold Streubel
    Department of Pathology, Medical University of Vienna, Vienna General Hospital, Vienna, Austria
    Am J Surg Pathol 30:529-36. 2006

Collaborators

Detail Information

Publications12

  1. ncbi Positron emission tomography with [18F] 2-fluoro-D-2- deoxyglucose in primary cutaneous T-cell lymphomas
    Julia Valencak
    Haematologica 89:115-6. 2004
  2. ncbi Carbamazepine-induced DRESS syndrome with recurrent fever and exanthema
    Julia Valencak
    Department of Dermatology, Division of General Dermatology, University of Vienna, Vienna, Austria
    Int J Dermatol 43:51-4. 2004
  3. ncbi Selective immunohistochemical staining shows significant prognostic influence of lymphatic and blood vessels in patients with malignant melanoma
    J Valencak
    Department of Dermatology, University of Vienna, Wahringer Gurtel 18 20, A 1090 Wien, Austria
    Eur J Cancer 40:358-64. 2004
    ..Our results demonstrate LMVD as a prognostic factor in malignant melanoma, although its prognostic relevance is much smaller compared with blood MVD...
  4. doi Dermal infiltrates of cutaneous T-cell lymphomas with epidermotropism but not other cutaneous lymphomas are abundant with langerin⁺ dendritic cells
    M Der-Petrossian
    Department of Dermatology, Division of General Dermatology, Medical University of Vienna, Vienna, Austria
    J Eur Acad Dermatol Venereol 25:922-7. 2011
    ..The Langerhans cell (LC) hypothesis suggests that cutaneous T-cell lymphomas (CTCL) are diseases of chronic T-cell stimulation by LC-mediated antigen presentation...
  5. doi Prognostic relevance of hypoxia inducible factor-1alpha expression in patients with melanoma
    J Valencak
    Department of Dermatology, Medical University of Vienna, Vienna, Austria
    Clin Exp Dermatol 34:e962-4. 2009
    ..Our results indicate that HIF-1alpha overexpression is present in most primary melanomas, but is not associated with clinicopathological variables, patient prognosis or survival...
  6. doi Somatostatin receptor scintigraphy in primary cutaneous T- and B-cell lymphomas
    J Valencak
    Department of Dermatology, Medical University of Vienna, Vienna, Austria
    J Eur Acad Dermatol Venereol 24:13-7. 2010
    ..Monitoring and repeated staging is of substantial importance in many patients with primary cutaneous T-cell lymphomas (CTCL). For primary cutaneous B-cell lymphomas (CBCL), extensive initial staging is the mainstay for correct diagnosis...
  7. doi Rituximab monotherapy for primary cutaneous B-cell lymphoma: response and follow-up in 16 patients
    J Valencak
    Department of Dermatology, Medical University of Vienna, Austria
    Ann Oncol 20:326-30. 2009
    ..We have carried out a retrospective analysis to evaluate the therapeutic value of the anti-CD20 antibody rituximab in 16 consecutive patients with primary cutaneous CD20+ B-cell lymphomas...
  8. pmc Treatment of advanced pancreatic cancer with the long-acting somatostatin analogue lanreotide: in vitro and in vivo results
    M Raderer
    Department of Internal Medicine I, University of Vienna, Austria
    Br J Cancer 79:535-7. 1999
    ..In vitro data also demonstrated absence of SSTR2 expression, suggesting pancreatic cancer not to be a potential target for treatment with SST analogues...
  9. pmc Importance of extensive staging in patients with mucosa-associated lymphoid tissue (MALT)-type lymphoma
    M Raderer
    Department of Internal Medicine I, University of Vienna, Austria
    Br J Cancer 83:454-7. 2000
    ..In addition, our data suggest that extra-gastrointestinal MALT-type lymphoma more frequently occurs simultaneously at different anatomic sites than MALT-type lymphoma involving the GI-tract...
  10. ncbi Molecular cytogenetic evidence of t(14;18)(IGH;BCL2) in a substantial proportion of primary cutaneous follicle center lymphomas
    Berthold Streubel
    Department of Pathology, Medical University of Vienna, Vienna General Hospital, Vienna, Austria
    Am J Surg Pathol 30:529-36. 2006
    ..The reason(s) why BCL2 rearrangements escape the detection by PCR is (are) not clear but could be due to BCL2 mutations, breakpoints outside the amplified DNA, or a high load of somatic mutations...
  11. ncbi Somatostatin receptor scintigraphy with 111In-DOTA-lanreotide and 111In-DOTA-Tyr3-octreotide in patients with stage IV melanoma: in-vitro and in-vivo results
    Julia Valencak
    Department of Dermatology, Medical University of Vienna, Vienna, Austria
    Melanoma Res 15:523-9. 2005
    ..Judging from our data, however, there is no evidence of functional SST-R expression on melanoma cells...
  12. ncbi Identification of a melanoma marker derived from melanoma-associated endogenous retroviruses
    Johannes Humer
    Department of Dermatology, Division of General Dermatology, Green Hills Biotechnology GmbH, Gersthoferstrasse 29 31, 1180 Vienna, Austria
    Cancer Res 66:1658-63. 2006
    ..The prevalence of anti-MERV antibodies in melanoma patient sera was confirmed by immunofluorescence on env-transfected cells. These data indicate the potential of this candidate peptide as target for diagnosis and immunotherapy...